US equities |
NVDA $239.88 ▲+2.54% SPCX $169.77 ▲+6.80% MU $1,063.41 ▼-1.07% TSLA $379.58 ▲+2.43% SNDK $1,704.49 ▼-0.90% MSFT $528.74 ▲+2.17% INTC $116.10 ▼-2.71% META $743.35 ▲+2.10%
FinancialContent

Guardant Health, Inc. - Common Stock (NQ:GH)

186.44 +8.64 (+4.86%)
Delayed Quote Updated: 3:36 PM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Guardant Health, Inc. - Common Stock

< Previous 1 2
...
17 18 19 20 21 22 23 24 Next >
News headline image
Guardant Health Announces Collaboration With Daiichi Sankyo to Develop Guardant360® CDx as a Companion Diagnostic for Enhertu® in Advanced Metastatic Non-Small Cell Lung Cancer
From Guardant Health, Inc.
Via Business Wire
News headline image
Disruptor Alert: These 2 Companies Are Changing Cancer Care ↗
Their liquid biopsies are giving doctors new and better tools to spot, track, and treat cancers. 
Via The Motley Fool
News headline image
Guardant Health to Report First Quarter Financial Results on May 6, 2021
From Guardant Health, Inc.
Via Business Wire
News headline image
Data at AACR Demonstrate Growing Clinical Utility of Guardant Health Liquid Biopsies in the Treatment and Management of Advanced Cancers
From Guardant Health, Inc.
Via Business Wire
< Previous 1 2
...
17 18 19 20 21 22 23 24 Next >